Log in

PAR Par Drugs and Chemicals Limited NSE · India

Par Drugs and Chemicals (PAR) news

Top story · Aug 6, 2026 · Company press release

FOR RELEASE: CONTACT: New Hartford,

Source: 8-K filed Aug 6, 2026 on SEC EDGAR

Latest Par Drugs and Chemicals news

We have not published a story on Par Drugs and Chemicals yet. When there is news, it will appear here.

Questions about Par Drugs and Chemicals

What is the ticker symbol of Par Drugs and Chemicals?

Par Drugs and Chemicals Limited trades under the ticker PAR on NSE.

Where is Par Drugs and Chemicals listed?

Par Drugs and Chemicals Limited is listed on NSE.

Which country or territory is Par Drugs and Chemicals listed under?

Our directory records Par Drugs and Chemicals Limited under India.

What does Par Drugs and Chemicals do?

Our directory classifies Par Drugs and Chemicals Limited as: Drug manufacturing / APIs. This is a directory classification, not a description of the pipeline.

What is the ISIN of Par Drugs and Chemicals?

The ISIN recorded for Par Drugs and Chemicals Limited is INE04LG01015.

Does aibio.space cover Par Drugs and Chemicals?

aibio.space lists Par Drugs and Chemicals Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Par Drugs and Chemicals?

Companies in our directory listed in the same country and business area as Par Drugs and Chemicals: Astal Laboratories, Everest Organics, IOL Chemicals & Pharmaceuticals, Concord Biotech, Asston Pharmaceuticals, Sakar Healthcare.

Investor discussion: Par Drugs and Chemicals

Members talk about Par Drugs and Chemicals (PAR). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NSE:PAR on TradingView.

Listing details

Par Drugs and Chemicals Limited is a public biotech or pharmaceutical company listed on NSE under the ticker PAR, recorded under India. The directory classifies it as Drug manufacturing / APIs. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Par Drugs and Chemicals Limited
Ticker
PAR
Listing
NSE
Country or territory
India
Business scope
Drug manufacturing / APIs
ISIN
INE04LG01015
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.